S&P 500   3,012.32 (+0.19%)
DOW   26,908.25 (+0.30%)
QQQ   193.08 (-0.16%)
AAPL   241.94 (+0.59%)
FB   183.70 (-3.19%)
MSFT   137.75 (-0.49%)
GOOGL   1,245.99 (+0.14%)
AMZN   1,772.19 (-0.75%)
CGC   21.02 (+3.29%)
NVDA   196.40 (+0.20%)
MU   45.20 (-0.04%)
BABA   171.14 (-1.37%)
GE   8.92 (+1.36%)
TSLA   257.42 (+1.55%)
AMD   31.81 (-0.69%)
T   38.28 (+0.13%)
F   9.09 (+0.66%)
ACB   3.62 (-1.90%)
BAC   31.25 (+0.74%)
GILD   66.28 (+1.64%)
DIS   133.42 (+2.43%)
S&P 500   3,012.32 (+0.19%)
DOW   26,908.25 (+0.30%)
QQQ   193.08 (-0.16%)
AAPL   241.94 (+0.59%)
FB   183.70 (-3.19%)
MSFT   137.75 (-0.49%)
GOOGL   1,245.99 (+0.14%)
AMZN   1,772.19 (-0.75%)
CGC   21.02 (+3.29%)
NVDA   196.40 (+0.20%)
MU   45.20 (-0.04%)
BABA   171.14 (-1.37%)
GE   8.92 (+1.36%)
TSLA   257.42 (+1.55%)
AMD   31.81 (-0.69%)
T   38.28 (+0.13%)
F   9.09 (+0.66%)
ACB   3.62 (-1.90%)
BAC   31.25 (+0.74%)
GILD   66.28 (+1.64%)
DIS   133.42 (+2.43%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Amneal PharmaceuticalsCara TherapeuticsArQuleOdonate TherapeuticsOmeros
SymbolNYSE:AMRXNASDAQ:CARANASDAQ:ARQLNASDAQ:ODTNASDAQ:OMER
Price Information
Current Price$3.04$19.62$9.56$30.71$15.51
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$9.00$26.93$12.86N/A$27.75
% Upside from Price Target196.05% upside37.25% upside34.49% upsideN/A78.92% upside
Trade Information
Market Cap$888.30 million$784.76 million$1.10 billion$931.90 million$781.70 million
Beta1.512.222.241.772.84
Average Volume1,380,003597,7442,252,721104,810344,395
Sales & Book Value
Annual Revenue$1.86 billion$13.47 million$25.76 millionN/A$29.87 million
Price / Sales0.4958.3144.63N/A25.59
Cashflow$1.45 per shareN/AN/AN/AN/A
Price / Cash2.10N/AN/AN/AN/A
Book Value$3.00 per share$3.38 per share$0.72 per share$4.62 per share($2.04) per share
Price / Book1.015.8013.28N/A-7.60
Profitability
Net Income$-169,730,000.00$-74,010,000.00$-15,480,000.00$-88,960,000.00$-126,760,000.00
EPS$0.95($2.06)($0.16)($3.64)($2.22)
Trailing P/E Ratio3.20N/AN/AN/AN/A
Forward P/E Ratio4.05N/AN/AN/AN/A
P/E Growth$0.84N/AN/AN/AN/A
Net Margins-3.65%-420.97%-349.34%N/A-135.46%
Return on Equity (ROE)28.20%-68.36%-33.45%-78.04%N/A
Return on Assets (ROA)5.39%-46.96%-26.42%-68.36%-94.78%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio3.66%0.04%0.07%N/AN/A
Current Ratio2.17%3.11%12.54%9.61%1.62%
Quick Ratio1.41%3.11%12.54%9.61%1.59%
Ownership Information
Institutional Ownership Percentage34.79%64.92%85.25%96.52%53.13%
Insider Ownership Percentage26.34%5.80%13.80%59.30%12.80%
Miscellaneous
Employees6,0005536117236
Shares Outstanding299.09 million40.03 million120.26 million32.19 million49.29 million
Next Earnings Date11/6/2019 (Confirmed)11/5/2019 (Estimated)10/30/2019 (Confirmed)10/22/2019 (Estimated)11/14/2019 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable
 Amneal PharmaceuticalsCara TherapeuticsArQuleOdonate TherapeuticsOmeros

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel